Monopar Therapeutics Statistics

Total Valuation

MNPR has a market cap or net worth of $214.61 million. The enterprise value is $180.75 million.

Market Cap	214.61M
Enterprise Value	180.75M

Important Dates

The next estimated earnings date is Tuesday, May 20, 2025, before market open.

Earnings Date	May 20, 2025
Ex-Dividend Date	n/a

Share Statistics

MNPR has 6.11 million shares outstanding. The number of shares has increased by 37.09% in one year.

Current Share Class	6.11M
Shares Outstanding	6.11M
Shares Change (YoY)	+37.09%
Shares Change (QoQ)	+39.27%
Owned by Insiders (%)	4.60%
Owned by Institutions (%)	24.54%
Float	3.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.37
P/TBV Ratio	4.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.47

Current Ratio	11.47
Quick Ratio	11.46
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -51.42% and return on invested capital (ROIC) is -33.32%.

Return on Equity (ROE)	-51.42%
Return on Assets (ROA)	-29.87%
Return on Invested Capital (ROIC)	-33.32%
Return on Capital Employed (ROCE)	-29.37%
Revenue Per Employee	n/a
Profits Per Employee	-$974,151
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +950.28% in the last 52 weeks. The beta is 1.13, so MNPR's price volatility has been higher than the market average.

Beta (5Y)	1.13
52-Week Price Change	+950.28%
50-Day Moving Average	36.73
200-Day Moving Average	22.51
Relative Strength Index (RSI)	42.90
Average Volume (20 Days)	18,350

Short Selling Information

The latest short interest is 44,062, so 0.72% of the outstanding shares have been sold short.

Short Interest	44,062
Short Previous Month	46,841
Short % of Shares Out	0.72%
Short % of Float	1.25%
Short Ratio (days to cover)	1.57

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-16.16M
Pretax Income	-7.12M
Net Income	-15.59M
EBITDA	n/a
EBIT	-16.16M
Earnings Per Share (EPS)	-$4.11

Full Income Statement

Balance Sheet

The company has $60.21 million in cash and n/a in debt, giving a net cash position of $60.21 million or $9.85 per share.

Cash & Cash Equivalents	60.21M
Total Debt	n/a
Net Cash	60.21M
Net Cash Per Share	$9.85
Equity (Book Value)	55.04M
Book Value Per Share	9.02
Working Capital	55.04M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-6.40M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MNPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.09%
Shareholder Yield	-37.09%
Earnings Yield	-6.47%
FCF Yield	n/a

Analyst Forecast

The average price target for MNPR is $59.50, which is 69.47% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$59.50
Price Target Difference	69.47%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 13, 2024. It was a reverse split with a ratio of 0.2:1.

Last Split Date	Aug 13, 2024
Split Type	Reverse
Split Ratio	0.2:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2